A Phase II Study of Photodynamic Therapy With LEVULAN(R) Topical Solution + Blue Light Versus LEVULAN(R) Topical Solution Vehicle + Blue Light Using Spot and Broad Area Application and Incubation Times of 1, 2 and 3 Hours for the Treatment of Multiple Actinic Keratoses on the Face or Scalp.

Trial Profile

A Phase II Study of Photodynamic Therapy With LEVULAN(R) Topical Solution + Blue Light Versus LEVULAN(R) Topical Solution Vehicle + Blue Light Using Spot and Broad Area Application and Incubation Times of 1, 2 and 3 Hours for the Treatment of Multiple Actinic Keratoses on the Face or Scalp.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Dec 2013

At a glance

  • Drugs Aminolevulinic acid (Primary)
  • Indications Actinic keratosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Mar 2013 Results presented at the 71st Annual Meeting of the American Academy of Dermatology.
    • 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Apr 2012 Top-line results are expected by the end of 2012 as reported by DUSA Pharmaceuticals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top